ES2091649T3 - Uso de rifaximina y composiciones farmaceuticas que la contienen en el tratamiento de la dispepsia gastrica causada por helicobacter pylori. - Google Patents
Uso de rifaximina y composiciones farmaceuticas que la contienen en el tratamiento de la dispepsia gastrica causada por helicobacter pylori.Info
- Publication number
- ES2091649T3 ES2091649T3 ES94104308T ES94104308T ES2091649T3 ES 2091649 T3 ES2091649 T3 ES 2091649T3 ES 94104308 T ES94104308 T ES 94104308T ES 94104308 T ES94104308 T ES 94104308T ES 2091649 T3 ES2091649 T3 ES 2091649T3
- Authority
- ES
- Spain
- Prior art keywords
- contain
- pharmaceutical compositions
- treatment
- rifaximine
- helicobacter pylori
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 230000002496 gastric effect Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- NZCRJKRKKOLAOJ-XRCRFVBUSA-N rifaximin Chemical compound OC1=C(C(O)=C2C)C3=C4N=C5C=C(C)C=CN5C4=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O NZCRJKRKKOLAOJ-XRCRFVBUSA-N 0.000 title abstract 2
- 229960003040 rifaximin Drugs 0.000 title abstract 2
- 241000590002 Helicobacter pylori Species 0.000 title 1
- 201000006549 dyspepsia Diseases 0.000 title 1
- 229940037467 helicobacter pylori Drugs 0.000 title 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
Abstract
LA INVENCION SE REFIERE AL USO DEL ANTIBIOTICO DE RIFAMICINA CONOCIDO POR EL NOMBRE DE RAFAXIMIN (INN) Y A LAS COMPOSICIONES FARMACEUTICAS QUE LO CONTIENEN EN EL TRATAMIENTO ORAL DE LAS FORMAS DE DISPEPSIA GASTRICA PROVOCADAS POR LA BACTERIA CONOCIDA "HELICOBACTER PYLORI". EL RIFAXIMIN PUEDE ADMINISTRARSE EN CUALQUIER FORMA FARMACEUTICA ORAL, PARTICULARMENTE TABLETAS, CAPSULAS, TABLETAS RECUBIERTAS DE AZUCAR, GRANULOS Y JARABES QUE CONTENGAN ENTRE 200 Y 2000 MILIGRAMOS DE PRINCIPIO ACTIVO, EN DOSIS DIARIAS DE ENTRE 400 Y 2000 MILIGRAMOS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT93BO000099A IT1264494B1 (it) | 1993-03-23 | 1993-03-23 | Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2091649T3 true ES2091649T3 (es) | 1996-11-01 |
Family
ID=11338806
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94104308T Expired - Lifetime ES2091649T3 (es) | 1993-03-23 | 1994-03-18 | Uso de rifaximina y composiciones farmaceuticas que la contienen en el tratamiento de la dispepsia gastrica causada por helicobacter pylori. |
Country Status (11)
Country | Link |
---|---|
US (1) | US5352679A (es) |
EP (1) | EP0616808B1 (es) |
JP (1) | JP2755550B2 (es) |
KR (1) | KR0177846B1 (es) |
AT (1) | ATE142495T1 (es) |
CA (1) | CA2115381C (es) |
DE (1) | DE69400493T2 (es) |
DK (1) | DK0616808T3 (es) |
ES (1) | ES2091649T3 (es) |
GR (1) | GR3020984T3 (es) |
IT (1) | IT1264494B1 (es) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6902738B2 (en) * | 1994-05-02 | 2005-06-07 | Josman Laboratories, Inc. | Topical oral dosage forms containing bismuth compounds |
US6426085B1 (en) | 1994-05-02 | 2002-07-30 | Josman Laboratories Inc. | Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis |
US5834002A (en) | 1994-05-02 | 1998-11-10 | Josman Laboratories, Inc. | Chewing gum containing colloidal bismuth subcitrate |
US6379651B1 (en) | 1995-02-07 | 2002-04-30 | Josman Laboratories | Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases |
WO1996024341A1 (en) * | 1995-02-07 | 1996-08-15 | Narayan Krishnarao Athanikar | Concomitant treatment with bismuth and antibacterials |
US6372784B1 (en) | 1995-02-07 | 2002-04-16 | Josman Laboratories, Inc. | Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds |
US7048906B2 (en) * | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
US6861053B1 (en) * | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
US5981522A (en) * | 1995-09-01 | 1999-11-09 | Kaneka Corporation | Treatment of disease caused by infection of Helicobacter |
IT1290679B1 (it) * | 1997-02-14 | 1998-12-10 | Alfa Wassermann Spa | Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi. |
EP0861660B9 (en) * | 1997-02-28 | 2006-06-28 | Kaneka Corporation | Curative medicine for disease caused by infection of Helicobacter |
US7122525B2 (en) * | 2001-11-21 | 2006-10-17 | Activbiotics, Inc. | Targeted therapeutics and uses thereof |
AU2002364162A1 (en) * | 2001-12-13 | 2003-06-30 | Activbiotics, Inc. | Sulfhydryl rifamycins and uses thereof |
US7820652B2 (en) * | 2003-09-24 | 2010-10-26 | Activbiotics Pharma, Llc | Regimen for the administration of rifamycin-class antibiotics |
US20060210492A1 (en) * | 2005-03-02 | 2006-09-21 | Kodsi Robert E | Use of rifaximin for treatment and prevention of periodontal conditions |
US8003118B2 (en) * | 2005-03-02 | 2011-08-23 | Kodsi Robert E | Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis |
US20060210483A1 (en) * | 2005-03-02 | 2006-09-21 | Kodsi Robert E | Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections |
EP1698630B1 (en) | 2005-03-03 | 2014-09-03 | ALFA WASSERMANN S.p.A. | New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations |
ITBO20050123A1 (it) | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
ITMI20061692A1 (it) | 2006-09-05 | 2008-03-06 | Alfa Wassermann Spa | Uso di polioli per ottenere forme polimorfe stabili di rifaximina |
US20080161337A1 (en) * | 2007-01-03 | 2008-07-03 | Leonard Weinstock | Use of Rifaximin for the Treatment of Chronic Prostatitis |
ES2798253T3 (es) † | 2007-07-06 | 2020-12-10 | Lupin Ltd | Composiciones farmacéuticas de rifaximina |
CN102164599B (zh) | 2008-09-26 | 2014-07-23 | Aska制药株式会社 | 预防和/或治疗功能性胃肠障碍的药剂 |
DK2350096T3 (da) | 2008-10-02 | 2020-03-02 | Salix Pharmaceuticals Ltd | Fremgangsmåder til behandling af hepatisk encephalopati |
US20110035232A1 (en) | 2008-10-02 | 2011-02-10 | Salix Pharmaceuticals, Ltd. | Methods of treating hepatic encephalopathy |
WO2010044093A1 (en) * | 2008-10-16 | 2010-04-22 | Strides Arcolab Limited | Formulations containing rifaximin |
WO2011061519A2 (en) | 2009-11-23 | 2011-05-26 | Cipla Limited | Topical foam composition |
AU2010320653A1 (en) | 2009-11-23 | 2012-06-21 | Cipla Limited | Topical foam composition |
IT1398550B1 (it) | 2010-03-05 | 2013-03-01 | Alfa Wassermann Spa | Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo |
NZ607935A (en) | 2010-09-13 | 2015-01-30 | Cipla Ltd | Pharmaceutical compositions comprising rifaximin |
WO2012076832A1 (en) | 2010-12-09 | 2012-06-14 | Cipla Limited | Suppositories comprising rifaximin |
ITBO20110461A1 (it) | 2011-07-29 | 2013-01-30 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali. |
ES2621557T3 (es) | 2014-03-31 | 2017-07-04 | Euticals S.P.A. | Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas |
PL3546464T3 (pl) | 2014-05-12 | 2020-11-02 | Alfasigma S.P.A. | Sposób wytwarzania i zastosowanie postaci krystalicznej Tau rifaksyminy solwatowanej z DEGME |
MX2016016458A (es) * | 2014-06-30 | 2017-07-13 | Salix Pharmaceuticals Inc | Métodos para repetir tratamiento de síndrome del intestino irritable (ibs). |
US11224591B2 (en) | 2016-10-14 | 2022-01-18 | Cipla Limited | Pharmaceutical compositions comprising rifaximin |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1154655B (it) * | 1980-05-22 | 1987-01-21 | Alfa Farmaceutici Spa | Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica |
-
1993
- 1993-03-23 IT IT93BO000099A patent/IT1264494B1/it active IP Right Grant
- 1993-06-28 US US08/083,453 patent/US5352679A/en not_active Expired - Lifetime
-
1994
- 1994-02-10 CA CA002115381A patent/CA2115381C/en not_active Expired - Lifetime
- 1994-03-10 KR KR1019940004654A patent/KR0177846B1/ko active IP Right Grant
- 1994-03-17 JP JP6047045A patent/JP2755550B2/ja not_active Expired - Lifetime
- 1994-03-18 ES ES94104308T patent/ES2091649T3/es not_active Expired - Lifetime
- 1994-03-18 AT AT94104308T patent/ATE142495T1/de active
- 1994-03-18 DE DE69400493T patent/DE69400493T2/de not_active Expired - Lifetime
- 1994-03-18 EP EP94104308A patent/EP0616808B1/en not_active Expired - Lifetime
- 1994-03-18 DK DK94104308.5T patent/DK0616808T3/da active
-
1996
- 1996-09-12 GR GR960402279T patent/GR3020984T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3020984T3 (en) | 1996-12-31 |
ATE142495T1 (de) | 1996-09-15 |
CA2115381C (en) | 1999-01-05 |
CA2115381A1 (en) | 1994-09-24 |
EP0616808B1 (en) | 1996-09-11 |
EP0616808A1 (en) | 1994-09-28 |
IT1264494B1 (it) | 1996-09-24 |
DK0616808T3 (da) | 1996-09-30 |
US5352679A (en) | 1994-10-04 |
JP2755550B2 (ja) | 1998-05-20 |
DE69400493D1 (de) | 1996-10-17 |
ITBO930099A0 (it) | 1993-03-23 |
KR0177846B1 (ko) | 1999-03-20 |
ITBO930099A1 (it) | 1994-09-23 |
DE69400493T2 (de) | 1997-01-23 |
JPH06298768A (ja) | 1994-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2091649T3 (es) | Uso de rifaximina y composiciones farmaceuticas que la contienen en el tratamiento de la dispepsia gastrica causada por helicobacter pylori. | |
GT199900203A (es) | Composiciones de celecoxib. | |
AR065970A2 (es) | Una composicion farmaceutica oral solida que comprende una combinacion de metformin y glibenclamida y uso de dicha composicion | |
AR019031A1 (es) | Forma farmaceutica de dosificacion de efavirenz en capsula o tableta comprimida y metodo para su preparacion | |
ES2081531T3 (es) | Composiciones farmaceuticas que contienen rifaximina para el tratamiento de infecciones vaginales. | |
NO993520D0 (no) | Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon | |
ES2159591T3 (es) | Composicion de liberacion controlada. | |
IL142801A0 (en) | Pharmaceutical compositions containing an adenosine analog | |
TNSN04095A1 (en) | Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus | |
AR042977A1 (es) | Formulaciones farmaceuticas liquidas de palonosetron | |
ATE311227T1 (de) | Schnell-wirkende, gefrier-trocknete, orale, pharmazeutische formulierung für die behandlung von migräne | |
AR004510A1 (es) | Composiciones que comprenden amoxicilina y clavulanato, procedimientos para su preparacion y el uso de las composiciones para la fabricacion de unmedicamento | |
NO304113B1 (no) | Krystallinsk tiagabinhydrokloridmonohydrat, farmas°ytisk preparat som omfatter det, og anvendelse derav for fremstilling av et medikament | |
ES2179832T3 (es) | Formas de administracion orales con contenido en flupirtina solida, con liberacion controlada del principio activo. | |
DE60025503D1 (de) | Pharmazeutische Zusammensetzungen, die Faropenem Natrium und eine Diamineacetat Verbindung zur Verbesserung der Magen-Darm Trakt Absorption enthalten | |
BR0013106A (pt) | Composição farmacêutica flutuante, comprimido, e processo de prepapação de um comprimido. | |
AR011457A1 (es) | Sales de bismuto de antibioticos del grupo de la moenomicina, procedimiento para su preparacion, su utilizacion y medicamentos que contienen tales sales | |
DE59510583D1 (de) | Pharmazeutische zusammensetzung zur systemischen transdermalen verabreichung mit dem wirkstoff morphin-6-glucuronid | |
UY26176A1 (es) | Formas polimorfas de un citrato de azobiciclo (2,2,2) octan- 3-amina y sus composiciones farmacéuticas. | |
AR040764A1 (es) | Formulaciones farmaceuticas de epinastina, pseudoefedrina y metilefedrina | |
DK0612763T3 (da) | Cykliske angiopeptinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
AR026451A1 (es) | Compuestos heterociclicos sililados | |
ES2043567T1 (es) | Una composicion farmaceutica de liberacion controlada para uso oral que contiene farmacos anti-inflamatorios no esteroideos. | |
RU2003133155A (ru) | Способ эрадикации инфекции helicobacter pylori в желудке | |
GB914512A (en) | Novel therapeutic compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 616808 Country of ref document: ES |